Enter a job title or keyword

Senior Director Pricing Strategy & Contracting

MoonLake -


Job Location:

Jersey, NJ - USA

Monthly Salary: Not provided by the employer
Posted: 10 August 2026 (25 days ago)
Application Deadline: 7 November 2026
Vacancies: 1 Vacancy

Job Summary

Job Purpose
The Senior Director Pricing Strategy & Contracting is in line with pre-defined group policies responsible for building and executing the U.S. pricing contracting and access strategy for the companys launch assets. This role ensures pricing decisions are evidence-driven access-enabled and compliant with commercial and government regulations and will outline the pricing strategy considering the overall company strategy develop contracting frameworks manage gross-to-net (GTN) forecasting oversee payer deal analytics. As part of the core U.S. Market Access leadership team this individual will play a pivotal role in shaping the financial access profile and payer engagement strategy pre- and post-launch.
Your profile
Major Accountabilities
  • Pre-Launch (T24 to Launch)
    • Pricing strategy & landscape assessment: Outline U.S. pricing strategy considering the overall company strategy and incorporating competitive intelligence analog analysis and anticipated value differentiation
    • Forecasting & GTN modelling: Lead development of gross-to-net forecasts including payer-specific assumptions and waterfall modelling
    • Contracting strategy & frameworks: Execute U.S. payer contracting approach including rebate structures contract archetypes and value-based agreement considerations
    • Contracting infrastructure & governance: Develop compliant contracting processes escalation workflows approval governance and contract templates in collaboration with legal and compliance
    • Deal analytics: Create payer-specific contract models and simulations to assess financial and access trade-offs
    • Government pricing readiness: Oversee preparation for CMS submission requirements (AMP BP) Medicaid Drug Rebate Program setup and 340B eligibility and pricing strategy
    • Co-pay & affordability strategy: Provide pricing input into co-pay PAP and bridge program design from a GTN and access impact lens
    • Training & compliance: Conduct field pricing training and establish negotiation guardrails for payer account leads and field reimbursement managers
    • Payer collaboration: Collaborate with payer marketing and payer account leads to ensure a coherent value proposition aligned engagement strategy and field readiness
  • Post-Launch (T0 to T12 Months)
    • Performance monitoring: Track contract execution rebate pull-through and pricing performance against forecast
    • Contract analytics & optimization: Conduct post-deal ROI analysis to guide future contracting decisions and budget planning
    • Pricing governance: Lead pricing committee for post-launch actions such as rebating adjustments new payer agreements and lifecycle pricing in accordance with group pricing policies
    • Compliance & audit readiness: Maintain full documentation for all pricing and contracting decisions; support audits and internal reviews
    • GTN adjustments: Refine GTN waterfall based on real-world payer behavior formulary positioning and emerging access dynamics
    • Cross-functional support: Inform co-pay and affordability programs with pricing impact analysis as data becomes available
    • Lifecycle pricing: Support pricing decisions for new indications population expansions or competitive responses
    • Insights loop: Share learnings from contract and pricing performance with finance brand and access leadership to drive iterative improvement

Job Requirements

Education:
  • Bachelors degree required
  • Advanced degree (MSc MBA PhD PharmD or MD) strongly preferred
Experience:
  • 10 years of U.S. market access experience
  • Launch experience in Immunology products strongly preferred
  • Experience managing government pricing strategy and compliance (Medicaid AMP BP 340B)
  • Experience in building pricing governance and operational infrastructure from the ground up is a plus
Skills/knowledge/behavioural competencies:
  • Deep knowledge of U.S. payer landscape rebate structures gross-to-net forecasting and contracting frameworks
  • Proficiency in building deal analytics and GTN models and contract performance analytics etc.
  • Strong strategic thinking financial acumen and decision-making skills
  • Exceptional communication and negotiation skills with experience presenting to senior leadership
Why us
An exciting job opportunity awaits you!
MoonLake is a dynamic and innovative company pushing the boundaries of possibility and we are looking for passionate individuals to join our stellar team.

What we offer:
Learning Environment: An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Impactful Work: Contribute to ground-breaking projects that have the potential to transform global healthcare.
Flexibility and Balance:Enjoy a healthy work-life balance while making meaningful contributions to our team.
Career Growth: A clear path for career progression with the chance to take on more responsibilities as you develop your skills.
About us

MoonLake Immunotherapeuticsis a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab a novel investigational Nanobody for the treatment of the inflammatory disease to revolutionize outcomes for patients.

We continue to make significant progress in our Global Clinical Development Programs. The companys focus is on inflammatory diseases with a major unmet need including hidradenitis suppurativa and psoriatic arthritis conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug with hubs in Cambridge & Porto.

Further information is available at


Required Experience:

Exec


About Company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.We continue to make significant progress in our Glo ... View more

View Profile View Profile